Cargando…
MiR‐103 inhibiting cardiac hypertrophy through inactivation of myocardial cell autophagy via targeting TRPV3 channel in rat hearts
Cardiac hypertrophy is a common pathological change frequently accompanied by chronic hypertension and myocardial infarction. Nevertheless, the pathophysiological mechanisms of cardiac hypertrophy have never been elucidated. Recent studies indicated that miR‐103 expression was significantly decrease...
Autores principales: | Qi, Hanping, Ren, Jing, E, Mingyao, Zhang, Qianhui, Cao, Yonggang, Ba, Lina, Song, Chao, Shi, Pilong, Fu, Bowen, Sun, Hongli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378213/ https://www.ncbi.nlm.nih.gov/pubmed/30604587 http://dx.doi.org/10.1111/jcmm.14095 |
Ejemplares similares
-
Activation of transient receptor potential vanilloid 3 channel (TRPV3) aggravated pathological cardiac hypertrophy via calcineurin/NFATc3 pathway in rats
por: Zhang, Qianhui, et al.
Publicado: (2018) -
MSTN Attenuates Cardiac Hypertrophy through Inhibition of Excessive Cardiac Autophagy by Blocking AMPK /mTOR and miR-128/PPARγ/NF-κB
por: Qi, Hanping, et al.
Publicado: (2019) -
Neutrophil-like cell membrane-coated siRNA of lncRNA AABR07017145.1 therapy for cardiac hypertrophy via inhibiting ferroptosis of CMECs
por: Shi, Pilong, et al.
Publicado: (2021) -
Deletion of Neuropeptide Y Attenuates Cardiac Dysfunction and Apoptosis During Acute Myocardial Infarction
por: Huang, Wei, et al.
Publicado: (2019) -
Overexpression of TRPV3 Correlates with Tumor Progression in Non-Small Cell Lung Cancer
por: Li, Xiaolei, et al.
Publicado: (2016)